Literature DB >> 24815887

Artificial masculinization in tilapia involves androgen receptor activation.

Matan Golan1, Berta Levavi-Sivan2.   

Abstract

Estrogens have a pivotal role in natural female sexual differentiation of tilapia while lack of steroids results in testicular development. Despite the fact that androgens do not participate in natural sex differentiation, synthetic androgens, mainly 17-α-methyltestosterone (MT) are effective in the production of all-male fish in aquaculture. The sex inversion potency of synthetic androgens may arise from their androgenic activity or else as inhibitors of aromatase activity. The current study is an attempt to differentiate between the two alleged activities in order to evaluate their contribution to the sex inversion process and aid the search for novel sex inversion agents. In the present study, MT inhibited aromatase activity, when applied in vitro as did the non-aromatizable androgen dihydrotestosterone (DHT). In comparison, exposure to fadrozole, a specific aromatase inhibitor, was considerably more effective. Androgenic activity of MT was evaluated by exposure of Sciaenochromis fryeri fry to the substance and testing for the appearance of blue color. Flutamide, an androgen antagonist, administered concomitantly with MT, reduced the appearance of the blue color and the sex inversion potency of MT in a dose-dependent manner. In tilapia, administration of MT, fadrozole or DHT resulted in efficient sex inversion while flutamide reduced the sex inversion potency of all three compounds. In the case of MT and DHT the decrease in sex inversion efficiency caused by flutamide is most likely due to the direct blocking of the androgen binding to its cognate receptor. The negative effect of flutamide on the efficiency of the fadrozole treatment may indicate that the masculinizing activity of fadrozole may be attributed to excess, un-aromatized, androgens accumulated in the differentiating gonad. The present study shows that when androgen receptors are blocked, there is a reduction in the efficiency of sex inversion treatments. Our results suggest that in contrast to natural sex differentiation, during sex inversion treatments, androgens, either endogenous or exogenous, participate in inducing testicular differentiation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  17-α-Methyltestosterone; Aromatase; Fadrozole; Sex inversion; Tilapia

Mesh:

Substances:

Year:  2014        PMID: 24815887     DOI: 10.1016/j.ygcen.2014.04.026

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  5 in total

1.  Human food safety and environmental hazards associated with the use of methyltestosterone and other steroids in production of all-male tilapia.

Authors:  Nichrous Mlalila; Charles Mahika; Lonji Kalombo; Hulda Swai; Askwar Hilonga
Journal:  Environ Sci Pollut Res Int       Date:  2015-02-03       Impact factor: 4.223

2.  A single intronic single nucleotide polymorphism in splicing site of steroidogenic enzyme hsd17b1 is associated with phenotypic sex in oyster pompano, Trachinotus anak.

Authors:  Bin Fan; Dizhi Xie; Yanwei Li; Xulei Wang; Xin Qi; Shuisheng Li; Zining Meng; Xinghan Chen; Junyao Peng; Yongjian Yang; Yuanyou Li; Le Wang
Journal:  Proc Biol Sci       Date:  2021-11-17       Impact factor: 5.349

3.  Masculinization of Adult Gambusia holbrooki: A Case of Recapitulation of Protogyny in a Gonochorist?

Authors:  Ngoc Kim Tran; Tzu Nin Kwan; John Purser; Jawahar G Patil
Journal:  Biology (Basel)       Date:  2022-04-30

4.  Histological and transcriptomic effects of 17α-methyltestosterone on zebrafish gonad development.

Authors:  Stephanie Ling Jie Lee; Julia A Horsfield; Michael A Black; Kim Rutherford; Amanda Fisher; Neil J Gemmell
Journal:  BMC Genomics       Date:  2017-07-24       Impact factor: 3.969

5.  Effect of 17α-methyltestosterone (MT) on oxidation stress in the liver of juvenile GIFT tilapia, Oreochromis niloticus.

Authors:  Yao Zheng; Jianhong Qu; Liping Qiu; Limin Fan; Shunlong Meng; Chao Song; Xuwen Bing; Jiazhang Chen
Journal:  Springerplus       Date:  2016-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.